{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:40:57Z","timestamp":1777578057318,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.080","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:31:58Z","timestamp":1557250318000},"page":"3296-3302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8684-6506","authenticated-orcid":false,"given":"Rulin C.","family":"Hechter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Y.","family":"Tartof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina S.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-4643","authenticated-orcid":false,"given":"Allison","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huong Q.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-8533","authenticated-orcid":false,"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.080_b0005","article-title":"Impact of HIV on the burden and severity of influenza illness in Malawian adults: a prospective cohort and parallel case-control study","author":"Ho","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.080_b0010","article-title":"The effects of the attributable fFraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV-prevalence setting, South Africa, 2013\u20132015","author":"Tempia","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.080_b0015","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/320747","article-title":"Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City","volume":"32","author":"Fine","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.080_b0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1086\/313985","article-title":"Influenza in human immunodeficiency virus-infected patients during the 1997\u20131998 influenza season","volume":"31","author":"Radwan","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.080_b0025","doi-asserted-by":"crossref","first-page":"e0149104","DOI":"10.1371\/journal.pone.0149104","article-title":"Infection and the epidemiology of invasive pneumococcal disease (IPD) in South African adults and older children prior to the introduction of a pneumococcal conjugate vaccine (PCV)","volume":"11","author":"Meiring","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.080_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/apc.2016.0165","article-title":"Invasive pneumococcal disease among HIV-infected and HIV-uninfected adults in a large integrated healthcare system","volume":"30","author":"Marcus","year":"2016","journal-title":"AIDS Patient Care STDS."},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.080_b0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e32834dcf27","article-title":"Invasive pneumococcal disease among HIV-positive individuals, 2000\u20132009","volume":"26","author":"Yin","year":"2012","journal-title":"Aids"},{"issue":"9349","key":"10.1016\/j.vaccine.2019.04.080_b0040","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.080_b0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/QAI.0000000000001037","article-title":"Brief report: Seroprevalence of pertussis infection in HIV-infected adults in the United States","volume":"73","author":"Troy","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.080_b0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mi.2012.54","article-title":"Immunity to the respiratory pathogen Bordetella pertussis","volume":"5","author":"Higgs","year":"2012","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.080_b0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01974608","article-title":"Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient","volume":"13","author":"Colebunders","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.080_b0060","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/infdis\/161.6.1296","article-title":"Pertussis in an adult man infected with the human immunodeficiency virus","volume":"161","author":"Doebbeling","year":"1990","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.080_b0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JCM.42.2.847-849.2004","article-title":"Identification of Bordetella pertussis in a critically ill human immunodeficiency virus-infected patient by direct genotypical analysis of Gram-stained material and discrimination from B. holmesii by using a unique recA gene restriction enzyme site","volume":"42","author":"Vielemeyer","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.04.080_b0070","unstructured":"CDC. Recommended adult immunization schedule\u2014United States-2014. http:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/adult\/adult-schedule.pdf Accessed on."},{"issue":"Rr-4","key":"10.1016\/j.vaccine.2019.04.080_b0075","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2019.04.080_b0080","unstructured":"Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816\u20139."},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.080_b0085","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.ijid.2008.05.1226","article-title":"Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults","volume":"12","author":"Bailey","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.080_b0090","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/420740","article-title":"Hepatitis A and B vaccination practices for ambulatory patients infected with HIV","volume":"38","author":"Tedaldi","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.04.080_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ypmed.2011.04.015","article-title":"Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999\u20132008","volume":"53","author":"Durham","year":"2011","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.080_b0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/519165","article-title":"Predictors of influenza vaccination in HIV-infected patients in the United States, 1990\u20132002","volume":"196","author":"Gallagher","year":"2007","journal-title":"J Infect Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2019.04.080_b0105","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1016\/j.vaccine.2014.06.015","article-title":"Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients","volume":"32","author":"Valour","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.080_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/lgbt.2017.0109","article-title":"Human papillomavirus vaccine awareness among HIV-positive gay and bisexual men: A qualitative study","volume":"5","author":"Koskan","year":"2018","journal-title":"LGBT Health"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.080_b0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/hiv.12483","article-title":"Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey","volume":"18","author":"Harrison","year":"2017","journal-title":"HIV Med"},{"issue":"17","key":"10.1016\/j.vaccine.2019.04.080_b0120","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1097\/00002030-200012010-00018","article-title":"Effect of influenza vaccination on disease progression among HIV-infected persons","volume":"14","author":"Sullivan","year":"2000","journal-title":"Aids"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.080_b0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.vaccine.2011.11.105","article-title":"Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults","volume":"30","author":"Hakim","year":"2012","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.vaccine.2019.04.080_b0130","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1016\/j.vaccine.2011.05.040","article-title":"Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis","volume":"29","author":"Beyer","year":"2011","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2019.04.080_b0135","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2013.04.065","article-title":"Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil","volume":"31","author":"Ho","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.080_b0140","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.inf.0000237830.33228.c3","article-title":"Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy","volume":"25","author":"Abzug","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.080_b0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/infdis\/jis360","article-title":"Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults","volume":"206","author":"Flynn","year":"2012","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.080_b0150","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jinf.2010.09.030","article-title":"Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals","volume":"61","author":"Horster","year":"2010","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.080_b0155","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.080_b0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/cid\/cis871","article-title":"Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population","volume":"56","author":"Tseng","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.080_b0165","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4161\/hv.28559","article-title":"Systemic inflammatory reaction after pneumococcal vaccine: a case series","volume":"10","author":"von Elten","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.04.080_b0170","unstructured":"Package inserts and manufacturers for some US licensed vaccines and immunoglobulins. http:\/\/www.vaccinesafety.edu\/package_inserts.htm Accessed on: March 22, 2018."},{"issue":"36","key":"10.1016\/j.vaccine.2019.04.080_b0175","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.vaccine.2015.07.037","article-title":"Demographic characteristics of members of the vaccine safety datalink (VSD): A comparison with the United States population","volume":"33","author":"Sukumaran","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:34Z","timestamp":1759401154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":35,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19305687"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}